ScreenerHero

PHO Photocure ASA

OSL · NO · Healthcare · Drug Manufacturers - Specialty & Generic · photocure.com
48.50NOK-2.02%Mkt Cap: 122.03M $P/E: 16.67

Photocure ASA, together with its subsidiaries, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products. It operates through two segments, Commercial Franchise and De…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$64.13BUSDP/E 24.9
TAK
Takeda Pharmaceutical Company Limited
$59.16BUSD
TEVA
Teva Pharmaceutical Industries Limited
$45.78BUSDP/E 65.4
GALD
Galderma Group AG
$43.33BUSDP/E 56.1
HLN
Haleon plc
$40.72BUSDP/E 18.9
SDZ
Sandoz Group AG
$34.23BUSDP/E 59.2
HLN
Haleon plc
$32.92BUSDP/E 19.1
ZTS
Zoetis Inc.
$30.20BUSDP/E 12.0
UTHR
United Therapeutics Corporation
$22.85BUSDP/E 19.1
VTRS
Viatris Inc.
$20.03BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.06BUSDP/E 110.0
NBIX
Neurocrine Biosciences, Inc.
$14.36BUSDP/E 20.7
IPN
Ipsen S.A.
$12.68BUSDP/E 22.9
ELAN
Elanco Animal Health Incorporated
$11.26BUSD
RDY
Dr. Reddy's Laboratories Limited
$10.16BUSDP/E 27.7
KRK
Krka, d. d.
$8.71BUSDP/E 19.4
AMRX
Amneal Pharmaceuticals, Inc.
$6.84BUSDP/E 40.1
HLUN-B
H. Lundbeck A/S
$6.66BUSDP/E 11.8
ALKS
Alkermes plc
$6.73BUSDP/E 105.6
HIMS
Hims & Hers Health, Inc.
$6.55BUSD

Key Statistics

Company
Market Cap122.03M USD
Enterprise Value107.73M USD
Revenue (TTM)63.45M USD
Gross Profit45.86M USD
Net Income (TTM)-141.81K USD
Revenue/Share25.36 NOK
Last Price48.50 NOK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees99
CountryNO
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINNO0010000045
Valuation
P/E (Trailing)16.67
P/E (Forward)33.22
PEG14.90
EV/EBITDA8.88
EV/Revenue1.70
P/S1.92
P/B2.15
EPS (TTM)2.91
EPS (Forward)1.46
52W Range
46.257% of range79.80
52W High79.80 NOK
52W Low46.25 NOK
Profitability
Gross Margin92.12%
Oper. Margin-6.59%
EBITDA Margin19.11%
Profit Margin-0.28%
ROE-0.31%
ROA-0.21%
Growth
Revenue Growth5.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF2.96M USD
CapEx (TTM)2.03M USD
FCF Margin1.86%
FCF Yield0.97%
Net Debt-14.30M USD
Net Debt/EBITDA-1.18
Balance Sheet
Debt/Equity0.02
Current Ratio3.65
Quick Ratio3.11
Book Value/Sh22.54 NOK
Cash/Share6.03 NOK
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 NOK
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateMay 23, 2013
Pay Date—
Analyst Consensus
Rating—
Target (Mean)79.67 NOK
Upside (mean)+64.3%
Target Range75.00 NOK – 85.00 NOK
75.00+64.3% to mean85.00
# Analysts3
Ownership
Shares Out.26.92M
Float20.33M
Insiders2.39%
Institutions38.07%
Technical
SMA 5052.39 (-7.4%)
SMA 20061.56 (-21.2%)
Beta0.32
S&P 52W Chg15.84%
Avg Vol (30d)52.27K
Avg Vol (10d)67.67K
Technical Indicators
RSI (14)37.6
MACD-1.2835
MACD Signal-1.1882
MACD Hist.-0.0953
BB Upper53.38 NOK
BB Middle50.42 NOK
BB Lower47.46 NOK
BB Width11.73%
ATR (14)1.452 NOK
Vol Ratio (20d)0.54x